z-logo
open-access-imgOpen Access
SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension
Author(s) -
Gudmundur Johannsson,
Murray B. Gordon,
Michael Højby Rasmussen,
Ida Holme Håkonsson,
Claus Sværke,
Shigeyuki Tahara,
Koji Takano,
Beverly M. K. Biller
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-lb074
Subject(s) - lean body mass , placebo , medicine , adipose tissue , lipid profile , body mass index , growth hormone , endocrinology , hormone , body weight , cholesterol , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom